Showing results (131-140 of 178) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|January 4, 2023
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world studyLaure Gossec, Stefan Siebert, Paul Bergmans, et al.
Annals of the Rheumatic Diseases|December 12, 2013
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-upEva L Kneepkens, James Cheng-Chung Wei, Michael T Nurmohamed, et al.
JMIR Research Protocols|March 5, 2020
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled TrialBart F Seppen, Merel J L'ami, Sharon Duarte Dos Santos Rico, et al.
RMD Open|March 1, 2016
Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION studyRieke Alten, Hubert Nüßlein, Mauro Galeazzi, et al.
Clinical and Experimental Rheumatology|March 12, 2016
Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world studyHubert G Nüßlein, Rieke Alten, Mauro Galeazzi, et al.
The Journal of Rheumatology|November 3, 2018
Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY StudyRianne E van Bentum, Sjoerd C Heslinga, Michael T Nurmohamed, et al.
RMD Open|April 20, 2024
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatologyYaëlle R Besten, Laura Boekel, Maurice Steenhuis, et al.
Annals of the Rheumatic Diseases|June 24, 2021
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study resultsJosef S Smolen, Stefan Siebert, Tatiana V Korotaeva, et al.
The Journal of Rheumatology|November 17, 2010
Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot studyHennie G Raterman, Anna Jamnitski, Willem F Lems, et al.
Arthritis Research & Therapy|December 29, 2010
Surprising negative association between IgG1 allotype disparity and anti-adalimumab formation: a cohort studyGeertje M Bartelds, Els de Groot, Michael T Nurmohamed, et al.
Pageof 18